Skip Navigation
Skip to contents

Endocrinol Metab : Endocrinology and Metabolism

clarivate
OPEN ACCESS
SEARCH
Search

Author index

Page Path
HOME > BROWSE ARTICLES > Author index
Search
Chrysoula Boutari  (Boutari C) 2 Articles
Obesity and Metabolism
Association of Adipokines with Development and Progression of Nonalcoholic Fatty Liver Disease
Chrysoula Boutari, Nikolaos Perakakis, Christos Socrates Mantzoros
Endocrinol Metab. 2018;33(1):33-43.   Published online March 21, 2018
DOI: https://doi.org/10.3803/EnM.2018.33.1.33
  • 8,611 View
  • 141 Download
  • 111 Web of Science
  • 106 Crossref
AbstractAbstract PDFPubReader   ePub   

Nonalcoholic fatty liver disease (NAFLD) is a chronic liver disease affecting 30% of the general population and 40% to 70% of obese individuals. Adipose tissue plays a crucial role in its pathogenesis, as it produces and secretes pro- and anti-inflammatory cytokines called adipokines. Adiponectin and leptin have well-determined actions in terms of NAFLD pathophysiology. Adiponectin deficiency is associated with a pro-inflammatory condition, as it is observed in obesity and other metabolic disorders. On the other hand, increased leptin levels, above the normal levels, act as a pro-inflammatory stimulus. Regarding other adipokines (resistin, visfatin, chemerin, retinol-binding protein 4, irisin), data about their contribution to NAFLD pathogenesis and progression are inconclusive. In addition, pharmacological agents like thiazolidinediones (pioglitazone and rosiglitazone), that are used in the management of NAFLD exert favourable effects on adipokine levels, which in turn may contribute to the improvement of liver function. This review summarizes the current knowledge and developments in the association between adipokines and NAFLD and discusses possible therapeutic implications targeting the modulation of adipokine levels as a potential tool for the treatment of NAFLD.

Citations

Citations to this article as recorded by  
  • Proanthocyanidins-Based Synbiotics as a Novel Strategy for Nonalcoholic Fatty Liver Disease (NAFLD) Risk Reduction
    Wasitha P. D. W. Thilakarathna, H. P. Vasantha Rupasinghe
    Molecules.2024; 29(3): 709.     CrossRef
  • The role of novel adipokines and adipose-derived extracellular vesicles (ADEVs): Connections and interactions in liver diseases
    Lijun Xie, Huiying Wang, Jinying Hu, Zhuoying Liu, Fang Hu
    Biochemical Pharmacology.2024; 222: 116104.     CrossRef
  • Mechanisms and clinical relevance of the bidirectional relationship of viral infections with metabolic diseases
    Nikolaos Perakakis, Hani Harb, Benjamin G Hale, Zsuzsanna Varga, Charlotte Steenblock, Waldemar Kanczkowski, Vasileia Ismini Alexaki, Barbara Ludwig, Peter Mirtschink, Michele Solimena, Nicole Toepfner, Sebastian Zeissig, Manuel Gado, Irene Alma Abela, Fe
    The Lancet Diabetes & Endocrinology.2023; 11(9): 675.     CrossRef
  • Lipocalin‐2 activates hepatic stellate cells and promotes nonalcoholic steatohepatitis in high‐fat diet–fed Ob/Ob mice
    Kyung Eun Kim, Jaewoong Lee, Hyun Joo Shin, Eun Ae Jeong, Hye Min Jang, Yu Jeong Ahn, Hyeong Seok An, Jong Youl Lee, Meong Cheol Shin, Soo Kyoung Kim, Won Gi Yoo, Won Ho Kim, Gu Seob Roh
    Hepatology.2023; 77(3): 888.     CrossRef
  • Effect of Dietary Intervention, with or without Cointerventions, on Inflammatory Markers in Patients with Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis
    Renate L. Hall, Elena S. George, Audrey C. Tierney, Anjana J. Reddy
    Advances in Nutrition.2023; 14(3): 475.     CrossRef
  • The Anti-Obesity and Anti-Steatotic Effects of Chrysin in a Rat Model of Obesity Mediated through Modulating the Hepatic AMPK/mTOR/lipogenesis Pathways
    Ghaleb Oriquat, Inas M. Masoud, Maher A. Kamel, Hebatallah Mohammed Aboudeya, Marwa B. Bakir, Sara A. Shaker
    Molecules.2023; 28(4): 1734.     CrossRef
  • Association between caffeine intake and liver biomarkers in non-alcoholic fatty liver disease
    Kübra UÇAR, Evrim KAHRAMANOĞLU, Zeynep GÖKTAŞ
    Cukurova Medical Journal.2023; 48(1): 177.     CrossRef
  • Changes in liver enzymes are associated with changes in insulin resistance, inflammatory biomarkers and leptin in prepubertal children with obesity
    Rosario Valle-Martos, Luis Jiménez-Reina, Ramón Cañete, Rosario Martos, Miguel Valle, María Dolores Cañete
    Italian Journal of Pediatrics.2023;[Epub]     CrossRef
  • The key role of inflammation in the pathogenesis and management of obesity and CVD
    Chrysoula Boutari, Michael A. Hill, Claudio Procaccini, Giuseppe Matarese, Christos S. Mantzoros
    Metabolism.2023; 145: 155627.     CrossRef
  • Obesity and diabetes
    Chrysoula Boutari, Antea DeMarsilis, Christos S. Mantzoros
    Diabetes Research and Clinical Practice.2023; 202: 110773.     CrossRef
  • Identifying a distinct fibrosis subset of NAFLD via molecular profiling and the involvement of profibrotic macrophages
    Weiwei He, Yinxiang Huang, Xiulin Shi, Qingxuan Wang, Menghua Wu, Han Li, Qiuhong Liu, Xiaofang Zhang, Caoxin Huang, Xuejun Li
    Journal of Translational Medicine.2023;[Epub]     CrossRef
  • The emerging significance of mitochondrial targeted strategies in NAFLD treatment
    Tao Zhang, Yingli Nie, Jiliang Wang
    Life Sciences.2023; 329: 121943.     CrossRef
  • Association between leptin and NAFLD: a two-sample Mendelian randomization study
    Ziwei Guo, Hongbo Du, Yi Guo, Qian Jin, Ruijia Liu, Zhangjun Yun, Jiaxin Zhang, Xiaoke Li, Yong’an Ye
    European Journal of Medical Research.2023;[Epub]     CrossRef
  • Liver fat as risk factor of hepatic and cardiometabolic diseases
    Münevver Demir, Stefan R. Bornstein, Christos S. Mantzoros, Nikolaos Perakakis
    Obesity Reviews.2023;[Epub]     CrossRef
  • Circulating hormones in biopsy-proven steatotic liver disease and steatohepatitis: A Multicenter Observational Study
    Laura Valenzuela-Vallejo, Pavlina Chrysafi, Matina Kouvari, Valentina Guatibonza-Garcia, Sophia C. Mylonakis, Angeliki Katsarou, Ornella Verrastro, Georgios Markakis, Mohammed Eslam, Georgios Papatheodoridis, Geltrude Mingrone, Jacob George, Christos S. M
    Metabolism.2023; 148: 155694.     CrossRef
  • Linalool attenuates lipid accumulation and oxidative stress in metabolic dysfunction-associated steatotic liver disease via Sirt1/Akt/PPRA-α/AMPK and Nrf-2/HO-1 signaling pathways
    P. Tamilmani, V. V. Sathibabu Uddandrao, P. Chandrasekaran, G. Saravanan, Parim Brahma Naidu, S. Sengottuvelu, S. Vadivukkarasi
    Clinics and Research in Hepatology and Gastroenterology.2023; 47(10): 102231.     CrossRef
  • Uncovering the Cardiovascular Threat: A Comprehensive Examination of Liver Fibrosis and Subclinical Atherosclerosis in Non-alcoholic Fatty Liver Disease
    Niketa Sharma, Swarupa Chakole, Bhushan Wandile
    Cureus.2023;[Epub]     CrossRef
  • Fetal programming by androgen excess impairs liver lipid content and PPARg expression in adult rats
    Aimé Florencia Silva, Giselle Adriana Abruzzese, María José Ferrer, María Florencia Heber, Silvana Rocío Ferreira, Gloria Edith Cerrone, Alicia Beatriz Motta
    Journal of Developmental Origins of Health and Disease.2022; 13(3): 300.     CrossRef
  • Adipose tissue dysfunction and MAFLD in obesity on the scene of COVID-19
    Adryana Cordeiro, Amanda Ribamar, Andrea Ramalho
    Clinics and Research in Hepatology and Gastroenterology.2022; 46(3): 101807.     CrossRef
  • Comparison of bioelectrical impedance analysis, mass index, and waist circumference in assessing risk for non-alcoholic steatohepatitis
    Katherine J.P. Schwenger, Alexander Kiu, Maryam AlAli, Amnah Alhanaee, Sandra E. Fischer, Johane P. Allard
    Nutrition.2022; 93: 111491.     CrossRef
  • Unveiling the Role of the Fatty Acid Binding Protein 4 in the Metabolic-Associated Fatty Liver Disease
    Juan Moreno-Vedia, Josefa Girona, Daiana Ibarretxe, Lluís Masana, Ricardo Rodríguez-Calvo
    Biomedicines.2022; 10(1): 197.     CrossRef
  • Predictive and Diagnostic Value of Serum Adipokines in Pregnant Women with Intrahepatic Cholestasis
    Nazan Yurtcu, Canan Soyer Caliskan, Huri Guvey, Samettin Celik, Safak Hatirnaz, Andrea Tinelli
    International Journal of Environmental Research and Public Health.2022; 19(4): 2254.     CrossRef
  • Symposium review: Adipose tissue endocrinology in the periparturient period of dairy cows
    Susanne Häussler, Hassan Sadri, Morteza H. Ghaffari, Helga Sauerwein
    Journal of Dairy Science.2022; 105(4): 3648.     CrossRef
  • Rodent models and metabolomics in non-alcoholic fatty liver disease: What can we learn?
    Maria Martin-Grau, Vannina G Marrachelli, Daniel Monleon
    World Journal of Hepatology.2022; 14(2): 304.     CrossRef
  • Non-Alcoholic Fatty Liver Disease in HIV/HBV Patients – a Metabolic Imbalance Aggravated by Antiretroviral Therapy and Perpetuated by the Hepatokine/Adipokine Axis Breakdown
    Simona Alexandra Iacob, Diana Gabriela Iacob
    Frontiers in Endocrinology.2022;[Epub]     CrossRef
  • Protective Roles of Shilajit in Modulating Resistin, Adiponectin, and Cytokines in Rats with Non-alcoholic Fatty Liver Disease
    Baran Ghezelbash, Nader Shahrokhi, Mohammad Khaksari, Gholamreza Asadikaram, Maryam Shahrokhi, Sara Shirazpour
    Chinese Journal of Integrative Medicine.2022; 28(6): 531.     CrossRef
  • The pathophysiological mechanism between hypopituitarism and nonalcoholic fatty liver disease
    Xinhe Zhang, Haoyu Tian, Yiling Li
    iLIVER.2022; 1(1): 65.     CrossRef
  • Correlation of Adiponectin Gene Polymorphisms rs266729 and rs3774261 With Risk of Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis
    Yong-Tian Zheng, Tian-Mei Xiao, Chan-Xian Wu, Jin-Yan Cheng, Le-Yu Li
    Frontiers in Endocrinology.2022;[Epub]     CrossRef
  • An Overview of the TRP-Oxidative Stress Axis in Metabolic Syndrome: Insights for Novel Therapeutic Approaches
    Mizael C. Araújo, Suzany H. S. Soczek, Jaqueline P. Pontes, Leonardo A. C. Marques, Gabriela S. Santos, Gisele Simão, Laryssa R. Bueno, Daniele Maria-Ferreira, Marcelo N. Muscará, Elizabeth S. Fernandes
    Cells.2022; 11(8): 1292.     CrossRef
  • Skeletal muscle mass to visceral fat area ratio as a predictor of NAFLD in lean and overweight men and women with effect modification by sex
    Yoosun Cho, Yoosoo Chang, Seungho Ryu, Hyun‐Suk Jung, Chan‐won Kim, Hyungseok Oh, Mi Kyung Kim, Won Sohn, Hocheol Shin, Sarah H. Wild, Christopher D. Byrne
    Hepatology Communications.2022; 6(9): 2238.     CrossRef
  • The Perirenal Fat Thickness Was Associated with Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus
    Yuxian Yang, Shuting Li, Yuechao Xu, Jing Ke, Dong Zhao
    Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy.2022; Volume 15: 1505.     CrossRef
  • Non-alcoholic fatty liver disease development: A multifactorial pathogenic phenomena
    Aamir Bashir, Ajay Duseja, Arka De, Manu Mehta, Pramil Tiwari
    Liver Research.2022; 6(2): 72.     CrossRef
  • Relationship between Liver Stiffness and Steatosis in Obesity Conditions: In Vivo and In Vitro Studies
    Francesca Baldini, Mohamad Khalil, Alice Bartolozzi, Massimo Vassalli, Agostino Di Ciaula, Piero Portincasa, Laura Vergani
    Biomolecules.2022; 12(5): 733.     CrossRef
  • Nonalcoholic Steatohepatitis (NASH) and Atherosclerosis: Explaining Their Pathophysiology, Association and the Role of Incretin-Based Drugs
    Eleftheria Galatou, Elena Mourelatou, Sophia Hatziantoniou, Ioannis S. Vizirianakis
    Antioxidants.2022; 11(6): 1060.     CrossRef
  • The epidemiology of non-alcoholic steatohepatitis (NASH) in the United States between 2010-2020: a population-based study
    Osama Hamid, Ahmed Eltelbany, Abdul Mohammed, Khaled Alsabbagh Alchirazi, Sushrut Trakroo, Imad Asaad
    Annals of Hepatology.2022; 27(5): 100727.     CrossRef
  • Helicobacter Pylori-Induced Gastric Infections: From Pathogenesis to Novel Therapeutic Approaches Using Silver Nanoparticles
    Romelia Pop, Alexandru-Flaviu Tăbăran, Andrei Paul Ungur, Andrada Negoescu, Cornel Cătoi
    Pharmaceutics.2022; 14(7): 1463.     CrossRef
  • Traumatic brain injury alters the gut-derived serotonergic system and associated peripheral organs
    Natosha M. Mercado, Guanglin Zhang, Zhe Ying, Fernando Gómez-Pinilla
    Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease.2022; 1868(11): 166491.     CrossRef
  • Detangling the interrelations between MAFLD, insulin resistance, and key hormones
    Shreya C. Pal, Mohammed Eslam, Nahum Mendez-Sanchez
    Hormones.2022; 21(4): 573.     CrossRef
  • Historical Changes in Weight Classes and the Influence of NAFLD Prevalence: A Population Analysis of 34,486 Individuals
    Benjamin Kai Yi Nah, Cheng Han Ng, Kai En Chan, Caitlyn Tan, Manik Aggarwal, Rebecca Wenling Zeng, Jieling Xiao, Yip Han Chin, Eunice X. X. Tan, Yi Ping Ren, Douglas Chee, Jonathan Neo, Nicholas W. S. Chew, Michael Tseng, Mohammad Shadab Siddiqui, Arun J.
    International Journal of Environmental Research and Public Health.2022; 19(16): 9935.     CrossRef
  • Adipokines in Non-Alcoholic Fatty Liver Disease: Are We on the Road toward New Biomarkers and Therapeutic Targets?
    Vera Francisco, Maria Jesus Sanz, José T. Real, Patrice Marques, Maurizio Capuozzo, Djedjiga Ait Eldjoudi, Oreste Gualillo
    Biology.2022; 11(8): 1237.     CrossRef
  • Fatty Liver/Adipose Tissue Dual‐Targeting Nanoparticles with Heme Oxygenase‐1 Inducer for Amelioration of Obesity, Obesity‐Induced Type 2 Diabetes, and Steatohepatitis
    Juhyeong Hong, Yong‐Hee Kim
    Advanced Science.2022;[Epub]     CrossRef
  • Genome-wide association and Mendelian randomization study of fibroblast growth factor 21 reveals causal associations with hyperlipidemia and possibly NASH
    Susanna C. Larsson, Karl Michaëlsson, Marina Mola-Caminal, Jonas Höijer, Christos S. Mantzoros
    Metabolism.2022; 137: 155329.     CrossRef
  • Gender differences in the ideal cutoffs of visceral fat area for predicting MAFLD in China
    Pingping Yu, Huachao Yang, Xiaoya Qi, Ruixue Bai, Shouqin Zhang, Jianping Gong, Ying Mei, Peng Hu
    Lipids in Health and Disease.2022;[Epub]     CrossRef
  • Apelin and chemerin receptors are G protein-coupled receptors involved in metabolic as well as reproductive functions: Potential therapeutic implications?
    Anthony Estienne, Alice Bongrani, Pascal Froment, Joëlle Dupont
    Current Opinion in Endocrine and Metabolic Research.2021; 16: 86.     CrossRef
  • Metformin dose increase versus added linagliptin in non‐alcoholic fatty liver disease and type 2 diabetes: An analysis of the J‐LINK study
    Yasuji Komorizono, Kaori Hosoyamada, Naoko Imamura, Shoko Kajiya, Yasuhiro Hashiguchi, Norio Ueyama, Hirohiko Shinmaki, Nobuyuki Koriyama, Masako Tsukasa, Tetsuro Kamada
    Diabetes, Obesity and Metabolism.2021; 23(3): 832.     CrossRef
  • Gender Differences in the Relationships among Metabolic Syndrome and Various Obesity-Related Indices with Nonalcoholic Fatty Liver Disease in a Taiwanese Population
    I-Ting Lin, Mei-Yueh Lee, Chih-Wen Wang, Da-Wei Wu, Szu-Chia Chen
    International Journal of Environmental Research and Public Health.2021; 18(3): 857.     CrossRef
  • Leptin in Leanness and Obesity
    Nikolaos Perakakis, Olivia M. Farr, Christos S. Mantzoros
    Journal of the American College of Cardiology.2021; 77(6): 745.     CrossRef
  • Severe insulin resistance syndromes
    Angeliki M. Angelidi, Andreas Filippaios, Christos S. Mantzoros
    Journal of Clinical Investigation.2021;[Epub]     CrossRef
  • Liver Enzymes Correlate With Metabolic Syndrome, Inflammation, and Endothelial Dysfunction in Prepubertal Children With Obesity
    Rosario Valle-Martos, Miguel Valle, Rosario Martos, Ramón Cañete, Luis Jiménez-Reina, María Dolores Cañete
    Frontiers in Pediatrics.2021;[Epub]     CrossRef
  • From Nonalcoholic Fatty Liver Disease (NAFLD) to Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)—New Terminology in Pediatric Patients as a Step in Good Scientific Direction?
    Marta Flisiak-Jackiewicz, Anna Bobrus-Chociej, Natalia Wasilewska, Dariusz Marek Lebensztejn
    Journal of Clinical Medicine.2021; 10(5): 924.     CrossRef
  • Endoplasmic Reticulum Stress and Autophagy in the Pathogenesis of Non-alcoholic Fatty Liver Disease (NAFLD): Current Evidence and Perspectives
    Christina-Maria Flessa, Ioannis Kyrou, Narjes Nasiri-Ansari, Gregory Kaltsas, Athanasios G. Papavassiliou, Eva Kassi, Harpal S. Randeva
    Current Obesity Reports.2021; 10(2): 134.     CrossRef
  • Role of Insulin Resistance in MAFLD
    Yoshitaka Sakurai, Naoto Kubota, Toshimasa Yamauchi, Takashi Kadowaki
    International Journal of Molecular Sciences.2021; 22(8): 4156.     CrossRef
  • Elafibranor and liraglutide improve differentially liver health and metabolism in a mouse model of non‐alcoholic steatohepatitis
    Nikolaos Perakakis, Konstantinos Stefanakis, Michael Feigh, Sanne S. Veidal, Christos S. Mantzoros
    Liver International.2021; 41(8): 1853.     CrossRef
  • Metabolic Spectrum of Liver Failure in Type 2 Diabetes and Obesity: From NAFLD to NASH to HCC
    Hyunmi Kim, Da Som Lee, Tae Hyeon An, Hyun-Ju Park, Won Kon Kim, Kwang-Hee Bae, Kyoung-Jin Oh
    International Journal of Molecular Sciences.2021; 22(9): 4495.     CrossRef
  • Non-Alcoholic Fatty Liver Disease: Metabolic, Genetic, Epigenetic and Environmental Risk Factors
    Oriol Juanola, Sebastián Martínez-López, Rubén Francés, Isabel Gómez-Hurtado
    International Journal of Environmental Research and Public Health.2021; 18(10): 5227.     CrossRef
  • Serum Visfatin Levels in Nonalcoholic Fatty Liver Disease and Liver Fibrosis: Systematic Review and Meta-Analysis
    Abdulrahman Ismaiel, Daniel-Corneliu Leucuta, Stefan-Lucian Popa, Dan L. Dumitrascu
    Journal of Clinical Medicine.2021; 10(14): 3029.     CrossRef
  • Possible Hepatoprotective Effect of Tocotrienol-Rich Fraction Vitamin E in Non-alcoholic Fatty Liver Disease in Obese Children and Adolescents
    Farah D.R. Al-Baiaty, Aziana Ismail, Zarina Abdul Latiff, Khairul Najmi Muhammad Nawawi, Raja Affendi Raja Ali, Norfilza Mohd Mokhtar
    Frontiers in Pediatrics.2021;[Epub]     CrossRef
  • Adipokines in Insulin Resistance: Current Updates
    Utpal Jagdish Dongre
    Biosciences Biotechnology Research Asia.2021; 18(2): 357.     CrossRef
  • Metabolic Effects of Gastrectomy and Duodenal Bypass in Early Gastric Cancer Patients with T2DM: A Prospective Single-Center Cohort Study
    Young Ki Lee, Eun Kyung Lee, You Jin Lee, Bang Wool Eom, Hong Man Yoon, Young-Il Kim, Soo Jeong Cho, Jong Yeul Lee, Chan Gyoo Kim, Sun-Young Kong, Min Kyong Yoo, Yul Hwangbo, Young-Woo Kim, Il Ju Choi, Hak Jin Kim, Mi Hyang Kwak, Keun Won Ryu
    Journal of Clinical Medicine.2021; 10(17): 4008.     CrossRef
  • Chromium picolinate balances the metabolic and clinical markers in nonalcoholic fatty liver disease: a randomized, double-blind, placebo-controlled trial
    Fateme Kooshki, Fardin Moradi, Arash Karimi, Hamid Reza Niazkar, Manouchehr Khoshbaten, Vahid Maleki, Bahram Pourghassem Gargari
    European Journal of Gastroenterology & Hepatology.2021; 33(10): 1298.     CrossRef
  • Specificities of lipotoxicity of free fatty acids and cytokine profile in patients with chronic diffuse liver diseases
    V. I. Didenko, I. A. Klenina, О. M. Tatarchuk, O. I. Hrabovska, O. P. Petishko
    Regulatory Mechanisms in Biosystems.2021; 13(1): 3.     CrossRef
  • Markers of progression of liver fibrotic changes in patients with chronic toxic drug-induced hepatitis
    V.I. Didenko, O.M. Tatarchuk, O.P. Petishko, I.S. Konenko, S.L. Melanich
    GASTROENTEROLOGY.2021; 55(2): 91.     CrossRef
  • Long-term abuse of a high-carbohydrate diet is as harmful as a high-fat diet for development and progression of liver injury in a mouse model of NAFLD/NASH
    Simona Pompili, Antonella Vetuschi, Eugenio Gaudio, Alessandra Tessitore, Roberta Capelli, Edoardo Alesse, Giovanni Latella, Roberta Sferra, Paolo Onori
    Nutrition.2020; 75-76: 110782.     CrossRef
  • Targeted Analysis of Three Hormonal Systems Identifies Molecules Associated with the Presence and Severity of NAFLD
    Stergios A Polyzos, Nikolaos Perakakis, Chrysoula Boutari, Jannis Kountouras, Wael Ghaly, Athanasios D Anastasilakis, Asterios Karagiannis, Christos S Mantzoros
    The Journal of Clinical Endocrinology & Metabolism.2020; 105(3): e390.     CrossRef
  • Inflammatory Mechanisms of HCC Development
    Maria Grazia Refolo, Caterina Messa, Vito Guerra, Brian Irving Carr, Rosalba D’Alessandro
    Cancers.2020; 12(3): 641.     CrossRef
  • Mechanisms of Fibrosis Development in Nonalcoholic Steatohepatitis
    Robert F. Schwabe, Ira Tabas, Utpal B. Pajvani
    Gastroenterology.2020; 158(7): 1913.     CrossRef
  • Visceral-to-Subcutaneous Abdominal Fat Ratio Is Associated with Nonalcoholic Fatty Liver Disease and Liver Fibrosis
    Chan-Hee Jung, Eun-Jung Rhee, Hyemi Kwon, Yoosoo Chang, Seungho Ryu, Won-Young Lee
    Endocrinology and Metabolism.2020; 35(1): 165.     CrossRef
  • Alpha-syntrophin deficiency protects against non-alcoholic steatohepatitis associated increase of macrophages, CD8+ T-cells and galectin-3 in the liver
    Lisa Rein-Fischboeck, Elisabeth M. Haberl, Ganimete Bajraktari, Susanne Feder, Rebekka Pohl, Elke Eggenhofer, Christa Buechler
    Experimental and Molecular Pathology.2020; 113: 104363.     CrossRef
  • Targeting of Secretory Proteins as a Therapeutic Strategy for Treatment of Nonalcoholic Steatohepatitis (NASH)
    Kyeongjin Kim, Kook Hwan Kim
    International Journal of Molecular Sciences.2020; 21(7): 2296.     CrossRef
  • Non-Alcoholic Fatty Liver Disease Treatment in Patients with Type 2 Diabetes Mellitus; New Kids on the Block
    Vasilios G. Athyros, Stergios A. Polyzos, Jiannis Kountouras, Niki Katsiki, Panagiotis Anagnostis, Michael Doumas, Christos S. Mantzoros
    Current Vascular Pharmacology.2020; 18(2): 172.     CrossRef
  • High body mass index hinders fibrosis improvement in patients receiving long‐term tenofovir therapy in hepatitis B virus‐related cirrhosis
    Young Eun Chon, Kyu Sik Jung, Yeonjung Ha, Mi Na Kim, Joo Ho Lee, Seong Gyu Hwang, Sang Hoon Ahn, Do Young Kim, Kwang‐Hyub Han, Jun Yong Park
    Journal of Viral Hepatitis.2020; 27(11): 1119.     CrossRef
  • The role of omics in the pathophysiology, diagnosis and treatment of non-alcoholic fatty liver disease
    Nikolaos Perakakis, Konstantinos Stefanakis, Christos S. Mantzoros
    Metabolism.2020; 111: 154320.     CrossRef
  • The Selective Peroxisome Proliferator‐Activated Receptor Gamma Modulator CHS‐131 Improves Liver Histopathology and Metabolism in a Mouse Model of Obesity and Nonalcoholic Steatohepatitis
    Nikolaos Perakakis, Aditya Joshi, Natia Peradze, Konstantinos Stefanakis, Georgia Li, Michael Feigh, Sanne Skovgard Veidal, Glenn Rosen, Michael Fleming, Christos S. Mantzoros
    Hepatology Communications.2020; 4(9): 1302.     CrossRef
  • Osteocalcin and osteoprotegerin levels and their relationship with adipokines and proinflammatory cytokines in children with nonalcoholic fatty liver disease
    Doaa El Amrousy, Dalia El-Afify
    Cytokine.2020; 135: 155215.     CrossRef
  • The effect of saffron supplementation on some inflammatory and oxidative markers, leptin, adiponectin, and body composition in patients with nonalcoholic fatty liver disease: A double‐blind randomized clinical trial
    Farnaz Kavianipour, Naheed Aryaeian, Marjan Mokhtare, Reyhanesadat Mirnasrollahiparsa, Leila Jannani, Shahram Agah, Sodabeh Fallah, Nariman Moradi
    Phytotherapy Research.2020; 34(12): 3367.     CrossRef
  • Hepatic Lipidomics and Molecular Imaging in a Murine Non-Alcoholic Fatty Liver Disease Model: Insights into Molecular Mechanisms
    Ricardo Rodríguez-Calvo, Sara Samino, Josefa Girona, Neus Martínez-Micaelo, Pere Ràfols, María García-Altares, Sandra Guaita-Esteruelas, Alexandra Junza, Mercedes Heras, Oscar Yanes, Xavier Correig, Lluis Masana
    Biomolecules.2020; 10(9): 1275.     CrossRef
  • The effect of adiponectin in the pathogenesis of non-alcoholic fatty liver disease (NAFLD) and the potential role of polyphenols in the modulation of adiponectin signaling
    Samukelisiwe C. Shabalala, Phiwayinkosi V. Dludla, Lawrence Mabasa, Abidemi P. Kappo, Albertus K. Basson, Carmen Pheiffer, Rabia Johnson
    Biomedicine & Pharmacotherapy.2020; 131: 110785.     CrossRef
  • NAD+ metabolism: pathophysiologic mechanisms and therapeutic potential
    Na Xie, Lu Zhang, Wei Gao, Canhua Huang, Peter Ernst Huber, Xiaobo Zhou, Changlong Li, Guobo Shen, Bingwen Zou
    Signal Transduction and Targeted Therapy.2020;[Epub]     CrossRef
  • Neurochemical regulators of food behavior for pharmacological treatment of obesity: current status and future prospects
    Gayane Sargis Vardanyan, Hasmik Samvel Harutyunyan, Michail Iosif Aghajanov, Ruben Sargis Vardanyan
    Future Medicinal Chemistry.2020; 12(20): 1865.     CrossRef
  • Unraveling the Role of Leptin in Liver Function and Its Relationship with Liver Diseases
    Maite Martínez-Uña, Yaiza López-Mancheño, Carlos Diéguez, Manuel A. Fernández-Rojo, Marta G. Novelle
    International Journal of Molecular Sciences.2020; 21(24): 9368.     CrossRef
  • Roles of Adipokines in Digestive Diseases: Markers of Inflammation, Metabolic Alteration and Disease Progression
    Ming-Ling Chang, Zinger Yang, Sien-Sing Yang
    International Journal of Molecular Sciences.2020; 21(21): 8308.     CrossRef
  • CHANGES IN CARBOHYDRATE METABOLISM AND ADIPOCYTOKINES UNDER THE INFLUENCE OF TREATMENT OF PATIENTS WITH ALCOHOLIC CIRRHOSIS OF THE LIVER IN COMBINATION WITH OBESITY USING ADAMETHIONINUM AND ARGININE GLUTAMATE
    N. R. Matkovska
    Medical and Clinical Chemistry.2020; (3): 17.     CrossRef
  • Effects of sodium-glucose co-transporter-2 (SGLT2) inhibitors on non-alcoholic fatty liver disease/non-alcoholic steatohepatitis: Ex quo et quo vadimus?
    Niki Katsiki, Nikolaos Perakakis, Christos Mantzoros
    Metabolism.2019; 98: iii.     CrossRef
  • Role of Soluble Adiponectin Receptor 2 in Non-Alcoholic Fatty Liver Disease in Children
    Gulsah Kaya Aksoy, Reha Artan, Cihat Aksoy, Sebahat Özdem, Atike Atalay, Aygen Yılmaz
    Pediatric Gastroenterology, Hepatology & Nutrition.2019; 22(5): 470.     CrossRef
  • Determinants of ectopic liver fat in metabolic disease
    Anja Bosy-Westphal, Wiebke Braun, Viktoria Albrecht, Manfred J. Müller
    European Journal of Clinical Nutrition.2019; 73(2): 209.     CrossRef
  • Involvement of the hepatic branch of the vagus nerve in the regulation of plasma adipokine levels in rats fed a high-fructose diet
    Naoto Hashimoto, Manabu Wakagi, Katsunari Ippoushi, Yuko Takano-Ishikawa
    The Journal of Nutritional Biochemistry.2019; 71: 90.     CrossRef
  • Fat and Sugar—A Dangerous Duet. A Comparative Review on Metabolic Remodeling in Rodent Models of Nonalcoholic Fatty Liver Disease
    Ines C.M. Simoes, Justyna Janikiewicz, Judith Bauer, Agnieszka Karkucinska-Wieckowska, Piotr Kalinowski, Agnieszka Dobrzyń, Andrzej Wolski, Maciej Pronicki, Krzysztof Zieniewicz, Paweł Dobrzyń, Marcin Krawczyk, Hans Zischka, Mariusz R. Wieckowski, Yaiza P
    Nutrients.2019; 11(12): 2871.     CrossRef
  • Childhood obesity: increased risk for cardiometabolic disease and cancer in adulthood
    Susann Weihrauch-Blüher, Peter Schwarz, Jan-Henning Klusmann
    Metabolism.2019; 92: 147.     CrossRef
  • Effects of moderate-intensity continuous training and high-intensity interval training on serum levels of Resistin, Chemerin and liver enzymes in Streptozotocin-Nicotinamide induced Type-2 diabetic rats
    Parastesh Mohammad, Khosravi Zadeh Esfandiar, Saremi Abbas, Rekabtalae Ahoora
    Journal of Diabetes & Metabolic Disorders.2019; 18(2): 379.     CrossRef
  • Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics
    Stergios A. Polyzos, Jannis Kountouras, Christos S. Mantzoros
    Metabolism.2019; 92: 82.     CrossRef
  • The Latest Insights into Adipokines in Diabetes
    Won Kon Kim, Kwang-Hee Bae, Sang Chul Lee, Kyoung-Jin Oh
    Journal of Clinical Medicine.2019; 8(11): 1874.     CrossRef
  • Postprandial leptin and adiponectin in response to sugar and fat in obese and normal weight individuals
    M. A. Larsen, V. T. Isaksen, E. J. Paulssen, R. Goll, J. R. Florholmen
    Endocrine.2019; 66(3): 517.     CrossRef
  • First demonstration of protective effects of purified mushroom polysaccharide-peptides against fatty liver injury and the mechanisms involved
    Shuang Zhao, Shuman Zhang, Weiwei Zhang, Yi Gao, Chengbo Rong, Hexiang Wang, Yu Liu, Jack Ho Wong, Tzibun Ng
    Scientific Reports.2019;[Epub]     CrossRef
  • Applying Non-Invasive Fibrosis Measurements in NAFLD/NASH: Progress to Date
    Somaya Albhaisi, Arun J. Sanyal
    Pharmaceutical Medicine.2019; 33(6): 451.     CrossRef
  • Adiponectin rs2241766 and rs266729 gene polymorphisms in non-alcoholic fatty liver disease
    Aida A. Mahmoud, Hoda M. Moghazy, Laila M. Yousef, Asmaa N. Mohammad
    Gene Reports.2019; 15: 100381.     CrossRef
  • Non-invasive diagnosis of non-alcoholic steatohepatitis and fibrosis with the use of omics and supervised learning: A proof of concept study
    Nikolaos Perakakis, Stergios A. Polyzos, Alireza Yazdani, Aleix Sala-Vila, Jannis Kountouras, Athanasios D. Anastasilakis, Christos S. Mantzoros
    Metabolism.2019; 101: 154005.     CrossRef
  • Association between Helicobacter pylori infection and nonalcoholic fatty liver
    Rongqiang Liu, Qiuli Liu, Ying He, Wenqing Shi, Qianhui Xu, Qing Yuan, Qi Lin, Biao Li, Lei Ye, Youlan Min, Peiwen Zhu, Yi Shao
    Medicine.2019; 98(44): e17781.     CrossRef
  • CHANGES IN CARBOHYDRATE METABOLISM IN PATIENTS WITH ALCOHOLIC CIRRHOSIS OF THE LIVER ASSOCIATED WITH NON-ALCOHOLIC FATTY LIVER DISEASE DEPENDING ON THE STAGE OF DECOMPENSATION
    Nataliia Matkovska, Nataliia Virstiuk, Uliana Balan
    International Academy Journal Web of Scholar.2019; (6(36)): 17.     CrossRef
  • Non-alcoholic fatty liver disease and colorectal cancer: A marker of risk or common causation?
    Niki Katsiki, Dimitri P. Mikhailidis, Christos Mantzoros
    Metabolism.2018; 87: A10.     CrossRef
  • Critical Roles of microRNAs in the Pathogenesis of Fatty Liver: New Advances, Challenges, and Potential Directions
    Chenggui Miao, Zhongwen Xie, Jun Chang
    Biochemical Genetics.2018; 56(5): 423.     CrossRef
  • Alpha-syntrophin dependent expression of tubulin alpha 8 protein in hepatocytes
    Lisa Rein-Fischboeck, Ganimete Bajraktari, Rebekka Pohl, Susanne Feder, Kristina Eisinger, Wolfgang Mages, Elisabeth M. Haberl, Christa Buechler
    Journal of Physiology and Biochemistry.2018; 74(4): 511.     CrossRef
  • Pathogenesis of Nonalcoholic Steatohepatitis and Hormone-Based Therapeutic Approaches
    Kook Hwan Kim, Myung-Shik Lee
    Frontiers in Endocrinology.2018;[Epub]     CrossRef
  • Helicobacter pyloriand extragastric diseases: A review
    Antonietta Gerarda Gravina, Rocco Maurizio Zagari, Cristiana De Musis, Lorenzo Romano, Carmelina Loguercio, Marco Romano
    World Journal of Gastroenterology.2018; 24(29): 3204.     CrossRef
  • Thiazolidinedione induces a therapeutic effect on hepatosteatosis by regulating stearoyl‑CoA desaturase‑1, lipase activity, leptin and resistin
    Hessah Al‑Muzafar, Kamal Amin
    Experimental and Therapeutic Medicine.2018;[Epub]     CrossRef
  • Impact of weight cycling on CTRP3 expression, adipose tissue inflammation and insulin sensitivity in C57BL/6J mice
    Xin Li, Li Jiang, Miao Yang, Yu‑Wen Wu, Jia‑Zhong Sun
    Experimental and Therapeutic Medicine.2018;[Epub]     CrossRef
  • Analysis of non‑alcoholic fatty liver disease microRNA expression spectra in rat liver tissues
    Jiao Nie, Chang‑Ping Li, Jue‑Hong Li, Xia Chen, Xiaoling Zhong
    Molecular Medicine Reports.2018;[Epub]     CrossRef
Close layer
Decreasing Lean Body Mass with Age: Challenges and Opportunities for Novel Therapies
Chrysoula Boutari, Christos S. Mantzoros
Endocrinol Metab. 2017;32(4):422-425.   Published online December 14, 2017
DOI: https://doi.org/10.3803/EnM.2017.32.4.422
  • 4,812 View
  • 37 Download
  • 14 Web of Science
  • 17 Crossref
PDFPubReader   

Citations

Citations to this article as recorded by  
  • Soluble Factors Associated with Denervation-induced Skeletal Muscle Atrophy
    Marianny Portal Rodríguez, Claudio Cabello-Verrugio
    Current Protein & Peptide Science.2024; 25(3): 189.     CrossRef
  • Four-level regulation of lifespan through the biopsychological clock
    Tatiana Nikolaevna Berezina
    Психолог.2023; (5): 146.     CrossRef
  • The Impact of Obesity on the Health of the Older Population: A Cross-Sectional Study on the Relationship between Health-Related Quality of Life and Body Mass Index across Different Age Groups
    Patrick Reinbacher, Alexander Draschl, Maria Anna Smolle, Andrzej Hecker, Franz Gaderer, Kay-Bernd Lanner, Paul Ruckenstuhl, Patrick Sadoghi, Andreas Leithner, Stefan Nehrer, Thomas Klestil, Kevin Brunnader, Gerwin A. Bernhardt
    Nutrients.2023; 16(1): 51.     CrossRef
  • Acute Responses to Resistance Training on Body Composition, Muscular Fitness and Flexibility by Sex and Age in Healthy War Veterans Aged 50–80 Years
    Mario Kasović, Lovro Štefan, Zvonimir Kalčik
    Nutrients.2022; 14(16): 3436.     CrossRef
  • Use of Personal Resources May Influence the Rate of Biological Aging Depending on Individual Typology
    Tatiana N. Berezina, Stanislav A. Rybtsov
    European Journal of Investigation in Health, Psychology and Education.2022; 12(12): 1793.     CrossRef
  • Presbylarynx: Does Body Muscle Mass Correlate With Vocal Atrophy? A Prospective Case Control Study
    Mariline Santos, Susana V. Freitas, David Dias, Joana Costa, Miguel Coutinho, Cecília A. Sousa, Álvaro M. da Silva
    The Laryngoscope.2021;[Epub]     CrossRef
  • Weight-adjusted waist index reflects fat and muscle mass in the opposite direction in older adults
    Nam Hoon Kim, Yousung Park, Nan Hee Kim, Sin Gon Kim
    Age and Ageing.2021; 50(3): 780.     CrossRef
  • The identification of established modifiable mid-life risk factors for cardiovascular disease which contribute to cognitive decline: Korean Longitudinal Study of Aging (KLoSA)
    Yebeen Ysabelle Boo, Otto-Emil Jutila, Meghan A. Cupp, Logan Manikam, Sung-Il Cho
    Aging Clinical and Experimental Research.2021; 33(9): 2573.     CrossRef
  • Severe insulin resistance syndromes
    Angeliki M. Angelidi, Andreas Filippaios, Christos S. Mantzoros
    Journal of Clinical Investigation.2021;[Epub]     CrossRef
  • Acceleration of Biological Aging and Underestimation of Subjective Age Are Risk Factors for Severe COVID-19
    Tatiana N. Berezina, Stanislav Rybtsov
    Biomedicines.2021; 9(8): 913.     CrossRef
  • Skeletal muscle atrophy: From mechanisms to treatments
    Lin Yin, Na Li, Weihua Jia, Nuoqi Wang, Meidai Liang, Xiuying Yang, Guanhua Du
    Pharmacological Research.2021; 172: 105807.     CrossRef
  • Personal characteristics affecting the biological age of the individual
    Tatiana Berezina, Kirill Buzanov, A. Zheltenkov, A. Mottaeva
    E3S Web of Conferences.2021; 284: 09008.     CrossRef
  • Prevalence of low muscle mass and associated factors in community-dwelling older adults in Singapore
    Siew Ling Tey, Dieu Thi Thu Huynh, Yatin Berde, Geraldine Baggs, Choon How How, Yen Ling Low, Magdalin Cheong, Wai Leng Chow, Ngiap Chuan Tan, Samuel Teong Huang Chew
    Scientific Reports.2021;[Epub]     CrossRef
  • Physiological response and cardiorespiratory adaptation after a 6-week Nordic Walking training targeted at lipid oxidation in a group of post-menopausal women
    Agata Cebula, Anna Katarzyna Tyka, Aleksander Tyka, Tomasz Pałka, Wanda Pilch, Lidia Luty, Dariusz Mucha, Daniel Boullosa
    PLOS ONE.2020; 15(4): e0230917.     CrossRef
  • Age group and gender-wise comparison of obesity indices in subjects of Varanasi
    Kumar Sarvottam, Prabhat Ranjan, Umashree Yadav
    Indian Journal of Physiology and Pharmacology.2020; 64: 109.     CrossRef
  • Regular Black Bean Consumption Is Necessary to Sustain Improvements in Small-Artery Vascular Compliance in the Spontaneously Hypertensive Rat
    Jaime L. Clark, Tara B. Loader, Hope D. Anderson, Peter Zahradka, Carla G. Taylor
    Nutrients.2020; 12(3): 685.     CrossRef
  • Sarcopenia as a severe organ failure, its diagnosing and present therapeutic possibilities
    Eva Topinková
    Vnitřní lékařství.2018; 64(11): 1038.     CrossRef
Close layer

Endocrinol Metab : Endocrinology and Metabolism